174 related articles for article (PubMed ID: 22886820)
1. Arrhythmias in Fabry cardiomyopathy.
Acharya D; Robertson P; Kay GN; Jackson L; Warnock DG; Plumb VJ; Tallaj JA
Clin Cardiol; 2012 Dec; 35(12):738-40. PubMed ID: 22886820
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of an Implantable Loop Recorder to Detect Clinically Relevant Arrhythmias in Patients With Advanced Fabry Cardiomyopathy.
Weidemann F; Maier SK; Störk S; Brunner T; Liu D; Hu K; Seydelmann N; Schneider A; Becher J; Canan-Kühl S; Blaschke D; Bijnens B; Ertl G; Wanner C; Nordbeck P
Am J Cardiol; 2016 Jul; 118(2):264-74. PubMed ID: 27265676
[TBL] [Abstract][Full Text] [Related]
3. Study of indications for cardiac device implantation and utilisation in Fabry cardiomyopathy.
Vijapurapu R; Geberhiwot T; Jovanovic A; Baig S; Nordin S; Kozor R; Leyva F; Kotecha D; Wheeldon N; Deegan P; Rusk RA; Moon JC; Hughes DA; Woolfson P; Steeds RP
Heart; 2019 Dec; 105(23):1825-1831. PubMed ID: 31446426
[TBL] [Abstract][Full Text] [Related]
4. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
Anselme F; Moubarak G; Savouré A; Godin B; Borz B; Drouin-Garraud V; Gay A
Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
[TBL] [Abstract][Full Text] [Related]
5. Arrhythmias in Fabry cardiomyopathy.
Acharya D; Doppalapudi H; Tallaj JA
Card Electrophysiol Clin; 2015 Jun; 7(2):283-91. PubMed ID: 26002392
[TBL] [Abstract][Full Text] [Related]
6. Echocardiographic and clinical findings in patients with Fabry disease during long-term enzyme replacement therapy: a nationwide Danish cohort study.
Madsen CV; Bundgaard H; Rasmussen ÅK; Sørensen SS; Petersen JH; Køber L; Feldt-Rasmussen U; Petri H
Scand Cardiovasc J; 2017 Aug; 51(4):207-216. PubMed ID: 28545342
[TBL] [Abstract][Full Text] [Related]
7. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis.
Barra S; Duehmke R; Providencia R; Marijon E; Boveda S; Virdee M; Heck P; Fynn S; Begley D; Grace A; Agarwal S
Europace; 2018 Jan; 20(1):89-96. PubMed ID: 28031276
[TBL] [Abstract][Full Text] [Related]
8. Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study.
Takenaka T; Teraguchi H; Yoshida A; Taguchi S; Ninomiya K; Umekita Y; Yoshida H; Horinouchi M; Tabata K; Yonezawa S; Yoshimitsu M; Higuchi K; Nakao S; Anan R; Minagoe S; Tei C
J Cardiol; 2008 Feb; 51(1):50-9. PubMed ID: 18522775
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
Roses-Noguer F; Jarman JW; Clague JR; Till J
Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
[TBL] [Abstract][Full Text] [Related]
10. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A;
Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817
[TBL] [Abstract][Full Text] [Related]
11. Cardiac device implantation in Fabry disease: A retrospective monocentric study.
Sené T; Lidove O; Sebbah J; Darondel JM; Picard H; Aaron L; Fain O; Zenone T; Joly D; Charron P; Ziza JM
Medicine (Baltimore); 2016 Oct; 95(40):e4996. PubMed ID: 27749559
[TBL] [Abstract][Full Text] [Related]
12. Intracardiac alternans compared to surface T-wave alternans as a predictor of ventricular arrhythmias in humans.
Sandhu RK; Costantini O; Cummings JE; Poelzing S; Rosenbaum DS; Quan KJ
Heart Rhythm; 2008 Jul; 5(7):1003-8. PubMed ID: 18598955
[TBL] [Abstract][Full Text] [Related]
13. Hypertrophic cardiomyopathy: the importance of arrhythmic events in patients at risk for sudden cardiac death.
Medeiros Pde T; Martinelli Filho M; Arteaga E; Costa R; Siqueira S; Mady C; Piegas LS; Ramires JA
Arq Bras Cardiol; 2006 Nov; 87(5):649-57. PubMed ID: 17221043
[TBL] [Abstract][Full Text] [Related]
14. Comparison of transvenous vs subcutaneous defibrillator therapy in patients with cardiac arrhythmia syndromes and genetic cardiomyopathies.
Kuschyk J; Müller-Leisse J; Duncker D; Tülümen E; Fastenrath F; Fastner C; Kruska M; Akin I; Liebe V; Borggrefe M; Veltmann C; Rudic B
Int J Cardiol; 2021 Jan; 323():100-105. PubMed ID: 32871189
[TBL] [Abstract][Full Text] [Related]
15. Cardiac device implantation and device usage in Fabry and hypertrophic cardiomyopathy.
Vijapurapu R; Bradlow W; Leyva F; Moon JC; Zegard A; Lewis N; Kotecha D; Jovanovic A; Hughes DA; Woolfson P; Steeds RP; Geberhiwot T
Orphanet J Rare Dis; 2022 Jan; 17(1):6. PubMed ID: 34991670
[TBL] [Abstract][Full Text] [Related]
16. [Arrhythmia, device interventions and mortality analysis in patients with implanted cardioverter-defibrillator with/without resynchronisation therapy in dilative cardiomyopathy in primary prevention of sudden cardiac death].
Lelakowski J; Pudło J; Lelakowska-Pieła M; Rydlewska A; Piekarz J; Domaracki D
Pol Merkur Lekarski; 2016 Apr; 40(238):216-22. PubMed ID: 27137820
[TBL] [Abstract][Full Text] [Related]
17. High incidence of appropriate implantable cardioverter-defibrillator therapy in patients with syncope of unknown etiology and inducible ventricular arrhythmias.
Link MS; Costeas XF; Griffith JL; Colburn CD; Estes NA; Wang PJ
J Am Coll Cardiol; 1997 Feb; 29(2):370-5. PubMed ID: 9014991
[TBL] [Abstract][Full Text] [Related]
18. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
Wilkoff BL;
Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
[TBL] [Abstract][Full Text] [Related]
19. Right ventricular pacing is associated with increased rates of appropriate implantable cardioverter defibrillator shocks.
Arcinas LA; McIntyre WF; Farag A; Kushneriuk D; Hiebert B; Seifer CM
Ann Noninvasive Electrocardiol; 2019 Jul; 24(4):e12636. PubMed ID: 30719819
[TBL] [Abstract][Full Text] [Related]
20. Burden of Cardiac Arrhythmias in Patients With Anthracycline-Related Cardiomyopathy.
Mazur M; Wang F; Hodge DO; Siontis BL; Beinborn DS; Villarraga HR; Lerman A; Friedman PA; Herrmann J
JACC Clin Electrophysiol; 2017 Feb; 3(2):139-150. PubMed ID: 29759386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
